The tumor was diagnosed as estrogen receptor-positive, human epidermal growth factor receptor 2 (HER2)-positive invasive ductal carcinoma from core needle biopsy (Fig. 2a–c). Here, ERBB2 is linked to invasive ductal breast carcinoma.